Annual FCF
-$188.89 M
-$32.17 M-20.53%
31 December 2023
Summary:
Dyne Therapeutics annual free cash flow is currently -$188.89 million, with the most recent change of -$32.17 million (-20.53%) on 31 December 2023. During the last 3 years, it has fallen by -$141.22 million (-296.25%). DYN annual FCF is now -4294.77% below its all-time high of -$4.30 million, reached on 31 December 2018.DYN Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly FCF
-$74.88 M
-$19.16 M-34.38%
30 September 2024
Summary:
Dyne Therapeutics quarterly free cash flow is currently -$74.88 million, with the most recent change of -$19.16 million (-34.38%) on 30 September 2024. Over the past year, it has dropped by -$24.11 million (-47.50%). DYN quarterly FCF is now -916.18% below its all-time high of -$7.37 million, reached on 30 June 2020.DYN Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
TTM FCF
-$244.42 M
-$24.11 M-10.95%
30 September 2024
Summary:
Dyne Therapeutics TTM free cash flow is currently -$244.42 million, with the most recent change of -$24.11 million (-10.95%) on 30 September 2024. Over the past year, it has dropped by -$60.91 million (-33.19%). DYN TTM FCF is now -3159.41% below its all-time high of -$7.50 million, reached on 31 March 2020.DYN TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
DYN Free Cash Flow Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
---|---|---|---|
1 y1 year | -20.5% | -47.5% | -33.2% |
3 y3 years | -296.3% | -169.0% | -114.6% |
5 y5 years | -4294.8% | - | - |
DYN Free Cash Flow High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
---|---|---|---|---|---|---|---|
3 y | 3 years | -296.3% | at low | -169.0% | +4.9% | -114.6% | at low |
5 y | 5 years | -4294.8% | at low | -916.2% | +4.9% | -3159.4% | at low |
alltime | all time | -4294.8% | at low | -916.2% | +4.9% | -3159.4% | at low |
Dyne Therapeutics Free Cash Flow History
Date | Annual | Quarterly | TTM |
---|---|---|---|
Sept 2024 | - | -$74.88 M(+34.4%) | -$244.42 M(+10.9%) |
June 2024 | - | -$55.73 M(-29.2%) | -$220.31 M(-0.1%) |
Mar 2024 | - | -$78.73 M(+124.4%) | -$220.48 M(+16.7%) |
Dec 2023 | -$188.89 M(+20.5%) | -$35.09 M(-30.9%) | -$188.89 M(+2.9%) |
Sept 2023 | - | -$50.77 M(-9.2%) | -$183.51 M(+4.0%) |
June 2023 | - | -$55.89 M(+18.6%) | -$176.43 M(+16.3%) |
Mar 2023 | - | -$47.14 M(+58.7%) | -$151.71 M(-3.2%) |
Dec 2022 | -$156.71 M | -$29.71 M(-32.0%) | -$156.71 M(-0.2%) |
Sept 2022 | - | -$43.69 M(+40.2%) | -$157.06 M(+11.2%) |
June 2022 | - | -$31.17 M(-40.2%) | -$141.20 M(-10.0%) |
Date | Annual | Quarterly | TTM |
---|---|---|---|
Mar 2022 | - | -$52.14 M(+73.5%) | -$156.92 M(+27.4%) |
Dec 2021 | -$123.18 M(+158.4%) | -$30.06 M(+8.0%) | -$123.18 M(+8.2%) |
Sept 2021 | - | -$27.83 M(-40.6%) | -$113.88 M(+16.1%) |
June 2021 | - | -$46.89 M(+154.8%) | -$98.09 M(+67.5%) |
Mar 2021 | - | -$18.40 M(-11.4%) | -$58.57 M(+22.9%) |
Dec 2020 | -$47.67 M(+253.6%) | -$20.76 M(+72.4%) | -$47.67 M(+77.1%) |
Sept 2020 | - | -$12.04 M(+63.4%) | -$26.91 M(+81.0%) |
June 2020 | - | -$7.37 M(-1.7%) | -$14.87 M(+98.3%) |
Mar 2020 | - | -$7.50 M | -$7.50 M |
Dec 2019 | -$13.48 M(+213.7%) | - | - |
Dec 2018 | -$4.30 M | - | - |
FAQ
- What is Dyne Therapeutics annual free cash flow?
- What is the all time high annual FCF for Dyne Therapeutics?
- What is Dyne Therapeutics annual FCF year-on-year change?
- What is Dyne Therapeutics quarterly free cash flow?
- What is the all time high quarterly FCF for Dyne Therapeutics?
- What is Dyne Therapeutics quarterly FCF year-on-year change?
- What is Dyne Therapeutics TTM free cash flow?
- What is the all time high TTM FCF for Dyne Therapeutics?
- What is Dyne Therapeutics TTM FCF year-on-year change?
What is Dyne Therapeutics annual free cash flow?
The current annual FCF of DYN is -$188.89 M
What is the all time high annual FCF for Dyne Therapeutics?
Dyne Therapeutics all-time high annual free cash flow is -$4.30 M
What is Dyne Therapeutics annual FCF year-on-year change?
Over the past year, DYN annual free cash flow has changed by -$32.17 M (-20.53%)
What is Dyne Therapeutics quarterly free cash flow?
The current quarterly FCF of DYN is -$74.88 M
What is the all time high quarterly FCF for Dyne Therapeutics?
Dyne Therapeutics all-time high quarterly free cash flow is -$7.37 M
What is Dyne Therapeutics quarterly FCF year-on-year change?
Over the past year, DYN quarterly free cash flow has changed by -$24.11 M (-47.50%)
What is Dyne Therapeutics TTM free cash flow?
The current TTM FCF of DYN is -$244.42 M
What is the all time high TTM FCF for Dyne Therapeutics?
Dyne Therapeutics all-time high TTM free cash flow is -$7.50 M
What is Dyne Therapeutics TTM FCF year-on-year change?
Over the past year, DYN TTM free cash flow has changed by -$60.91 M (-33.19%)